The session will not only underscore the current impact of online health communities but also provide a forward-looking perspective on their potential to shape the future of patient centered care.
Participating audience can get a detailed view on strategic use of online patient community is for real-time intelligence which helps decision makers in 3 ways:
• Explore the ways in which online patient communities contribute to empowering individuals in managing their health conditions
• Foster a platform for the exchange of insights, experiences, and best practices among healthcare professionals, researchers, and community advocates.
• Emphasize the importance of patient-centered approaches within online communities, ensuring that the needs and perspectives of patients remain at the forefront.
The presentation comprises two pivotal projects. The first utilizes AI-enhanced fMRI analysis to refine the pharmaceutical representative’s sales journey, providing deeper insights into physician behaviors and decisions. The second employs NeuroPricing™ Online, a reaction time-based method, to determine optimal pricing for an OTC drug. An advanced econometric AI model extended the findings from three initial countries to ten additional markets, demonstrating the potential of these combined techniques in global market analysis.
But exactly what challenges does CI and KM have to overcome in a changing our industry? How can we capitalize on experience and skills when the hybridization of work, the “great resignation” and turnover disperse the CI channels and weaken the transmission of knowledge internally?
If the tools are there, they are sometimes too numerous or poorly used. As Servier has just begun the reengineering of its CI&KM organization, we can walk the attendance through some key learnings coming from this transformation journey and how to navigate avoiding the mermaids of new technologies!
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
• Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
• Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
• Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.
Blockbuster Competitive Intelligence is a new framework that almost nobody knows. This framework maximizes the potential of a drug and increases the impact that you can have with competitive intelligence.
So, what is it and how can you leverage it?
Blockbuster Competitive Intelligence outlines how Competitive Intelligence is used to develop, launch, and commercialize a blockbuster drug (or a drug that is critical to the success of the organization).
Over the past two decades, we have worked with multiple blockbusters and potential blockbuster products. We have experimented and innovated successful approaches while working at Roche, and Novartis. With Atacana we continue to innovate and support the majority of the top 10 pharma companies helping their blockbuster competitive intelligence strategies.
In this interactive workshop, we will share with you our Blockbuster Competitive Intelligence framework and learn from other participants what it takes to develop a winning strategy.
Our goal is to help you maximize the potential of your product and your potential for your next career move!